Quick Answer
AVENUE THERAPEUTICS, INC. reported Total Assets of $2.93 million for the year ending 2025.
- AVENUE THERAPEUTICS, INC. showed an increase of +9.7% in Total Assets from 2024 to 2025.
- This data is from AVENUE THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $234.0 thousand | Q2 2017: $34.71 million | Q3 2017: $26.18 million | Q1 2018: $15.27 million | Q2 2018: $9.44 million | Q3 2018: $5.26 million | Q1 2019: $29.76 million | Q2 2019: $15.68 million | Q3 2019: $13.88 million | Q1 2020: $6.70 million | Q2 2020: $5.33 million | Q3 2020: $4.35 million | Q1 2021: $1.94 million | Q2 2021: $1.19 million | Q3 2021: $688.0 thousand | Q1 2022: $1.96 million | Q2 2022: $1.01 million | Q3 2022: $575.0 thousand | Q1 2023: $8.45 million | Q2 2023: $1.67 million | Q3 2023: $502.0 thousand | Q1 2024: $3.31 million | Q2 2024: $4.99 million | Q3 2024: $2.63 million | Q1 2025: $3.59 million | Q2 2025: $4.16 million | Q3 2025: $3.73 million.
- Over the full 10 years of available data (2016 to 2025), AVENUE THERAPEUTICS, INC.'s Total Assets has grown by 1,387.8%.
- Historical annual values: Fiscal year 2025: $2.93 million | Fiscal year 2024: $2.67 million | Fiscal year 2023: $1.85 million | Fiscal year 2022: $6.85 million | Fiscal year 2021: $3.96 million | Fiscal year 2020: $3.25 million | Fiscal year 2019: $8.92 million | Fiscal year 2018: $4.53 million | Fiscal year 2017: $22.17 million | Fiscal year 2016: $197.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: